➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Colorcon
Boehringer Ingelheim
AstraZeneca
Medtronic

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Patent: 9,969,724

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,969,724
Title:Factor IXa inhibitors
Abstract: In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or solvates thereof, or pharmaceutical compositions comprising one or more said compounds or pharmaceutically acceptable salts or solvates thereof, and methods for using said compounds or pharmaceutically acceptable salts or solvates thereof for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes. ##STR00001##
Inventor(s): Sakurada; Isao (Tokyo, JP), Hirabayashi; Tomokazu (Tokyo, JP), Maeda; Yoshitaka (Tokyo, JP), Nagasue; Hiroshi (Tokyo, JP), Mizuno; Takashi (Tokyo, JP), Xu; Jiayi (Marlboro, NJ), Zhang; Ting (Princeton Junction, NJ), Smith; Cameron (Montgomery Village, MD), Parker; Dann (Cranford, NJ)
Assignee: Merck Sharp & Dohme Corp. (Rahway, NJ) Mochida Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:15/303,310
Patent Claims:see list of patent claims

Details for Patent 9,969,724

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bayer Healthcare Pharmaceuticals Inc. TRASYLOL aprotinin Injection 020304 1993-12-29 ⤷  Try it Free 2034-04-16
Microbix Biosystems Inc. KINLYTIC urokinase For Injection 021846 1978-01-16 ⤷  Try it Free 2034-04-16
Genentech, Inc. TNKASE tenecteplase For Injection 103909 2000-06-02 ⤷  Try it Free 2034-04-16
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Harvard Business School
Baxter
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.